ALCON REFORM CAPSULAR TENSION RING

FDA Premarket Approval P010059 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a private label distributor agreement with alcon laboratories, inc. , fort worth, texas. The device will be marketed under the trade name alcon reform capsular tension rings (models actr10, actr11, and actr12).

DeviceALCON REFORM CAPSULAR TENSION RING
Generic NameRing, Endocapsular
ApplicantMORCHER GMBH
Date Received2004-01-20
Decision Date2004-03-15
PMAP010059
SupplementS001
Product CodeMRJ 
Advisory CommitteeOphthalmic
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address MORCHER GMBH kapuzinerweg 12 stuttgart, Wurttemberg-baden D-703-7037

Supplemental Filings

Supplement NumberDateSupplement Type
P010059Original Filing
S006 2016-08-02 Normal 180 Day Track No User Fee
S005
S004 2011-11-08 Normal 180 Day Track
S003 2007-03-19 Real-time Process
S002 2004-08-03 Normal 180 Day Track
S001 2004-01-20 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
04048509620004 P010059 007

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.